Abstract
FDG PET has been used for years in the diagnosis and recurrence of non small cell lung cancer (NSCLC). It has an important impact on patient management, and its coupling with CT for immediate fusion allows immediate localization and characterization of uptake. This article reviews the role of FDG PET-CT in the staging of NSCLC for the detection of metastatic disease.